1-8 of 8
Verena Wais
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treosulfan-Based Reduced-Toxicity Conditioning for Elderly Patients with High-Risk Myelodysplastic and Myeloproliferative Disease for Allogeneic Hematopoietic Stem Cell Transplantation

Adela Maria Neagoie, Verena Wais, Andrea Gantner, Jacqueline Schnell, Katrin Strauss, Conrad Weidt, Hartmut Dohner, Donald Werner Bunjes, Elisa Sala
Journal: Blood
Blood (2023) 142 (Supplement 1): 6956.
https://doi.org/10.1182/blood-2023-188767
Published: 2023
Journal Articles

Monitoring the in-Vivo Expansion and Persistence of CAR-T Cells As a Tool to Help Decision Making in Patients with Aggressive B-Cell Lymphoma

Daniel Fürst, Christine Neuchel, Adela Neagoie, Elisa Amann, Immanuel Rode, Angela Krauss, Hubert Schrezenmeier, Verena Wais, Hartmut Döhner, Andreas Viardot, Elisa Sala
Journal: Blood
Blood (2022) 140 (Supplement 1): 7527–7528.
https://doi.org/10.1182/blood-2022-169212
Published: 2022
Journal Articles

Feasibility and Efficacy of Romiplostim for the Treatment of Persistent Thrombocytopenia after Allogeneic Stem Cell Transplantation. a Single Centre Experience

Charlotte Sommer, Andrea Gantner, Verena Wais, Adela Neagoie, Jacqueline Schnell, Hartmut Döhner, Donald Bunjes, Elisa Sala
Journal: Blood
Blood (2022) 140 (Supplement 1): 7603–7604.
https://doi.org/10.1182/blood-2022-168543
Published: 2022
Journal Articles

COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience.

Adela Neagoie, Charlotte Sommer, Andrea Gantner, Verena Wais, Jacqueline Schnell, Hannah Simon, Andreas Viardot, Hartmut Döhner, Donald Bunjes, Elisa Sala
Journal: Blood
Blood (2021) 138 (Supplement 1): 4868.
https://doi.org/10.1182/blood-2021-151061
Published: 2021
Journal Articles

Risk Factors Determining the Outcome of Critically Ill Allogeneic Hematopoietic Stem Cell Transplantation Patients: Time to Step Down?

Verena Wais, MD, Carmen Huwe, Armin Imhof, Hendrik Bracht, Thanh Mai Anne Nguyen, MD, Elisa Sala, MD, Hartmut Döhner, MD, Stephanie von Harsdorf, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2135.
https://doi.org/10.1182/blood-2018-99-115280
Published: 2018
Journal Articles

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Elisa Sala, MD, Stephanie von Harsdorf, MD, Verena Wais, MD, Thanh Mai Anne Nguyen, MD, Raphael Beck, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4601.
https://doi.org/10.1182/blood-2018-99-114977
Published: 2018
Journal Articles

Eculizumab Therapy of Adult TA-TMA: A High Response Rate Is Associated with a High Infection-Related Mortality

Stephan R Bohl, Stephanie Harsdorf, Stefan Schoensteiner, Phyllis Schwarzwaelder, Katrina Scholl, Verena Wais, Lars Bullinger, MD, Hartmut Döhner, MD, Florian Kuchenbauer, Donald Bunjes
Journal: Blood
Blood (2016) 128 (22): 2255.
https://doi.org/10.1182/blood.V128.22.2255.2255
Published: 2016
Journal Articles

Reduced Intensity Conditioning with Fludarabine, BCNU and Melphalan (FBM) for Allogeneic Hematopoietic Cell Transplantation in Elderly AML Patients: Factors Predicting Outcome

Verena Wais, Stephan Bohl, Lukas Kündgen, Stephanie von Harsdorf, Katrina Scholl, Richard F. Schlenk, MD, Susanne Hofmann, C. Philipp Maier, Konstanze Döhner, MD, Maria-Veronica Teleanu, MD, Lars Bullinger, MD, Kathrin Drognitz, Jean-Charles Moulin, Martin Binnenhei, Martin Bentz, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Mark Ringhoffer, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5523.
https://doi.org/10.1182/blood.V126.23.5523.5523
Published: 2015